Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon Neville Westin, Kathleen N. Moore, Hye Sook Chon, Jung‐Yun Lee, Jessica Thomes Pepin, Michael Sundborg and 24 more

Rank
11 of 529
Percentile
top 2.1%
Where
Journal of Clinical Oncology, 2023
Citations
389

From the 2023 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.